Does ABATACEPT Cause Basal cell carcinoma? 852 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 852 reports of Basal cell carcinoma have been filed in association with ABATACEPT (ORENCIA). This represents 0.7% of all adverse event reports for ABATACEPT.
852
Reports of Basal cell carcinoma with ABATACEPT
0.7%
of all ABATACEPT reports
2
Deaths
659
Hospitalizations
How Dangerous Is Basal cell carcinoma From ABATACEPT?
Of the 852 reports, 2 (0.2%) resulted in death, 659 (77.3%) required hospitalization, and 27 (3.2%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
Yes, Basal cell carcinoma is listed as a known adverse reaction in the official FDA drug label for ABATACEPT.
What Other Side Effects Does ABATACEPT Cause?
Drug ineffective (35,212)
Rheumatoid arthritis (21,898)
Pain (19,783)
Arthralgia (18,536)
Joint swelling (18,453)
Contraindicated product administered (13,559)
Fatigue (13,087)
Drug intolerance (12,451)
Rash (12,168)
Arthropathy (11,099)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
ALENDRONATE (610)
Which ABATACEPT Alternatives Have Lower Basal cell carcinoma Risk?
ABATACEPT vs ABATACEPT SUBQ /ML
ABATACEPT vs ABCIXIMAB
ABATACEPT vs ABEMACICLIB
ABATACEPT vs ABILIFY
ABATACEPT vs ABIRATERONE